These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 28254411)

  • 1. Unveil the mysterious mask of cytokine-based immunotherapy for melanoma.
    Xu DH; Zhu Z; Xiao H; Wakefield MR; Bai Q; Nicholl MB; Ding VA; Fang Y
    Cancer Lett; 2017 May; 394():43-51. PubMed ID: 28254411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New drug targets in metastatic melanoma.
    Homet B; Ribas A
    J Pathol; 2014 Jan; 232(2):134-41. PubMed ID: 24027077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research progress in advanced melanoma.
    Luo C; Shen J
    Cancer Lett; 2017 Jul; 397():120-126. PubMed ID: 28385603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment for metastatic malignant melanoma: old drugs and new strategies.
    Mouawad R; Sebert M; Michels J; Bloch J; Spano JP; Khayat D
    Crit Rev Oncol Hematol; 2010 Apr; 74(1):27-39. PubMed ID: 19781957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant Treatments for Advanced Resectable Melanoma.
    Liu JY; Lowe M
    J Surg Oncol; 2019 Jan; 119(2):216-221. PubMed ID: 30589079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New therapeutic options in the medical management of advanced melanoma.
    Lutzky J
    Semin Cutan Med Surg; 2010 Dec; 29(4):249-57. PubMed ID: 21277538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New hope in metastatic melanoma treatment?].
    Guillot B
    Ann Dermatol Venereol; 2012 Oct; 139(10):693-4. PubMed ID: 23122388
    [No Abstract]   [Full Text] [Related]  

  • 8. Melanoma treatment's changing landscape.
    Jenks S
    J Natl Cancer Inst; 2014 Jun; 106(6):dju176. PubMed ID: 24907389
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunotherapy for advanced melanoma: fulfilling the promise.
    Gogas H; Polyzos A; Kirkwood J
    Cancer Treat Rev; 2013 Dec; 39(8):879-85. PubMed ID: 23725878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PD-L1 and immune escape: insights from melanoma and other lineage-unrelated malignancies.
    Frydenlund N; Mahalingam M
    Hum Pathol; 2017 Aug; 66():13-33. PubMed ID: 28694003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting oncogenic drivers and the immune system in melanoma.
    McArthur GA; Ribas A
    J Clin Oncol; 2013 Feb; 31(4):499-506. PubMed ID: 23248252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating molecular biomarkers into current clinical management in melanoma.
    Kudchadkar R; Gibney G; Sondak VK
    Methods Mol Biol; 2014; 1102():27-42. PubMed ID: 24258972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The systemic treatment of advanced cutaneous melanoma.
    Logan TF
    Facial Plast Surg Clin North Am; 2003 Feb; 11(1):75-85. PubMed ID: 15062290
    [No Abstract]   [Full Text] [Related]  

  • 14. Nivolumab: A Review in Advanced Melanoma.
    Scott LJ
    Drugs; 2015 Aug; 75(12):1413-24. PubMed ID: 26220912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical management of melanoma.
    Brown CK; Kirkwood JM
    Surg Clin North Am; 2003 Apr; 83(2):283-322, viii. PubMed ID: 12744611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy in the management of advanced cutaneous malignant melanoma.
    Luke JJ; Schwartz GK
    Clin Dermatol; 2013; 31(3):290-7. PubMed ID: 23608448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanoma: from darkness to promise.
    Gasent Blesa JM; Grande Pulido E; Alberola Candel V; Provencio Pulla M
    Am J Clin Oncol; 2011 Apr; 34(2):179-87. PubMed ID: 20498590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual fronts poised to transform melanoma therapy.
    Mullard A
    Nat Rev Drug Discov; 2011 May; 10(5):325-6. PubMed ID: 21532549
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug clinics. How I treat cutaneous melanoma].
    Piérard-Franchimont C; Piérard GE
    Rev Med Liege; 1998 Jan; 53(1):4-6. PubMed ID: 9555173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No longer an untreatable disease: how targeted and immunotherapies have changed the management of melanoma patients.
    Girotti MR; Saturno G; Lorigan P; Marais R
    Mol Oncol; 2014 Sep; 8(6):1140-58. PubMed ID: 25178978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.